載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知,但若此問題持續,請透過
電郵支援widget工具
聯絡我們。
HK
前往
勁減45%
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
WarrenAI
收起
Basilea Pharmaceutica AG
SWX:BSLN
瑞士 / 保健 / 生物科技
加入觀察名單
貨幣
CHF
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
市盈率倍數
股價
44.85
CHF
公允價值
37.47
CHF
Metrics
Range
Conclusion
Selected LTM P/E Multiple
4.8x - 5.3x
5.1x
Selected Fwd P/E Multiple
8.3x - 9.2x
8.8x
Fair Value
CHF 35.60 - CHF 39.35
CHF 37.47
Upside
-20.6% - -12.3%
-16.4%
Benchmarks
-
Full Ticker
Molecular Partners AG
-
SWX:MOLN
DBV Technologies S.A.
-
ENXTPA:DBV
argenx SE
-
ENXTBR:ARGX
Pharma Mar, S.A.
-
BME:PHM
Zealand Pharma A/S
-
CPSE:ZEAL
Basilea Pharmaceutica AG
-
SWX:BSLN
-
-
-
Multiples Valuation: Price / EPS
分享
儲存
股價
44.85
CHF
公允價值
37.47
CHF
看漲
-16.4%
Price / LTM EPS Multiple
Price / Fwd EPS Multiple
Fair Value
Benchmark Editor
Select Price / LTM EPS Ratio
Benchmark Companies
MOLN
DBV
ARGX
PHM
ZEAL
BSLN
SWX:MOLN
ENXTPA:DBV
ENXTBR:ARGX
BME:PHM
CPSE:ZEAL
SWX:BSLN
Historical Net Income Growth
5Y CAGR
NM-
NM-
NM-
NM-
NM-
NM-
3Y CAGR
NM-
NM-
NM-
-34.5%
NM-
NM-
Latest Twelve Months
12.8%
-42.9%
382.3%
881.0%
-53.3%
642.4%
Historical Net Income Profit Margin
5 Year Average Margin
-564.0%
-1752.3%
-225.4%
25.7%
-758.9%
2.2%
Prior Fiscal Year
-880.7%
-462.4%
-23.3%
0.7%
-205.3%
6.6%
Latest Fiscal Year
-1087.4%
-2744.4%
37.1%
14.9%
-1720.9%
37.2%
Latest Twelve Months
-1087.4%
-2744.4%
37.1%
11.3%
-1720.9%
37.2%
Current Trading Multiples
EV / LTM EBITDA
0.4x
NA
-2214.4x
105.7x
-20.4x
8.5x
Price / LTM Sales
24.9x
56.7x
17.7x
7.6x
547.6x
2.6x
LTM P/E Ratio
-2.3x
-2.1x
47.8x
66.8x
-31.8x
7.0x
Low
Mid
High
Benchmark LTM P/E Ratio
-31.8x
-2.1x
66.8x
Historical LTM P/E Ratio
-97.6x
7.0x
84.0x
Selected P/E Multiple
4.8x
5.1x
5.3x
(x) LTM Net Income
78
78
78
(=) Equity Value
374
393
413
(/) Shares Outstanding
12.1
12.1
12.1
Implied Value Range
30.81
32.43
34.05
FX Rate: CHF/CHF
1.0
1.0
1.0
Market Price
Implied Value Range (Trading Cur)
30.81
32.43
34.05
44.85
Upside / (Downside)
-31.3%
-27.7%
-24.1%
支援算式
Equity Waterfall
Financials
Historical Multiples
Equity Value
Benchmark Companies
(in millions)
MOLN
DBV
ARGX
PHM
ZEAL
BSLN
Value of Common Equity
123
235
39,735
1,328
34,328
544
(/) Shares Outstanding
36.9
136.7
61.1
17.6
70.7
12.1
Implied Stock Price
3.35
1.72
650.76
75.55
485.70
44.85
FX Conversion Rate to Trading Currency
1.00
1.13
1.13
1.00
1.00
1.00
Implied Stock Price (Trading Cur)
3.35
1.52
575.60
75.55
485.70
44.85
Trading Currency
CHF
EUR
EUR
EUR
DKK
CHF
FX Rate to Reporting Currency
1.00
1.13
1.13
1.00
1.00
1.00
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी